PODCAST · news
Marketstrat Pulse Insights
by Marketstrat
The executive briefing for MedTech leaders. Each week, Marketstrat breaks down the critical signals in Medical Imaging, AI, and Go-to-Market strategy. We cut through the noise to tell you not just what happened, but what it means for your strategy. Hosted by Zara, Marketstrat's AI Analyst. Guest narration by Marcus.
Episodes
-
The Operating Denominator: Radiology Partners’ Everlight Acquisition, 4DMedical & Actinium-225 Supply
Episode Description / Show Notes: 🎙️ Hosted by Zara, Marketstrat's automated AI voice. The medical imaging market is moving from permission-led commercialization toward operating models that control recurring case volume, workflow execution, qualified supply, and real-world performance. This…
more -
Operating Proof Over Permission: Pro Medicus’ AUD 261M Scale, Vitestro Robotics & FDA GenAI Guidance
🎙️ Hosted by Zara, Marketstrat's automated AI voice. The healthcare technology market is officially exiting the era of one-time regulatory permissions. Competitive advantage is moving ruthlessly toward continuous operating proof—converting access into activated workflow, measuring real-world...
-
Monetization Control: Teledyne’s $1.1B Acquisition, RadNet’s $105M ARR & Case-Volume Economics
The medical imaging industry's center of gravity is shifting beyond simple regulatory authorizations and pilot agreements. Durable commercial value now concentrates with companies that control the underlying monetization rails—whether owning the physical component, the deployed workflow, or the...
-
The Capacity Control Stack: GE’s $500M Care Alliance, Automation Bias & Theranostic Supply
Healthcare operators and investors are witnessing a decisive structural shift: imaging value is aggressively moving away from standalone asset ownership and toward the capacity-control stack. This week on Marketstrat Pulse Insights, automated host Zara breaks down why capital and commercial...
-
The 2027 OPPS Reset: SaMS Payments, Cardiac Staging & Ultrasound Capacity
Episode Description / Show Notes:The medical imaging AI market is facing a profound structural divergence between reimbursable clinical services and provider-funded productivity tools. This week on Marketstrat Pulse Insights, automated host Zara breaks down the regulatory and commercial shifts...
-
Beyond Clearance Counts: Supervised Report Drafting, Breast-AI Layering & Kaiser’s Capacity Proof
The medical imaging market has officially moved past algorithm clearance counts as the primary measure of commercial success. Capital and strategic advantage are now flowing directly toward assets that command governed reporting, high-volume platform layering, and measurable capacity release.…
more -
Pulse Insights: Imaging AI’s Edge Shifts from Clearance to Fleet Capacity (June 19, 2026)
Welcome to the Marketstrat Pulse Insights audio briefing for the week ending June 19, 2026. In this edition, automated host Zara breaks down the fundamental structural shift occurring across the medical imaging AI ecosystem. As regulatory clearance becomes table stakes, commercial leadership is...
-
The Reporting Control Plane: RadNet's $250M Move, SIIM 2026 & The WISeR AI Backlash
The commercial center of gravity in medical imaging AI has broken away from standalone detection models. The new high-stakes competitive battleground is reporting-layer control. This week on Marketstrat Pulse Insights, automated host Zara breaks down the ground-truth commercial signals from the...
-
Platform Control over Point Solutions: Philips’ WellSpan Alliance, ProtégéAI+ 2.0 & Aetna's 15% Margin Cut
Episode Description / Show Notes:The medical imaging infrastructure market is undergoing a massive structural shift: platform control is entirely replacing point solutions. If a technology does not explicitly command a workflow bottleneck—like scanner utilization, radiologist reporting, or...
-
Platform Control & Synthetic Capacity: The AUD 3.4B I-MED Deal, SubtleHD & Modality Repricing
The medical imaging infrastructure market is undergoing an aggressive repricing. The commercial center of gravity has definitively shifted from standalone AI detection models to outright platform control. This week on Marketstrat Pulse Insights, automated host Zara breaks down why assets that…
more -
Infrastructure & Capacity Control: 1-Hour Bedside MRI, X-Ray AI Expansion & Supply Chain Realities
The medical imaging AI market has crossed a massive structural threshold. Value is moving definitively away from standalone detection models toward infrastructure that dictates hospital capacity control. This week on Marketstrat Pulse Insights, automated host Zara breaks down the high-signal...
-
From Model Proof to Capacity Control: RadNet's AI Leverage, GE's Freelium & Siemens Optiq
The medical imaging AI market has crossed a massive threshold. The industry's focus has officially shifted from simply proving standalone models work to controlling the workflow and physically expanding hospital capacity. This week on Marketstrat Pulse Insights, virtual host Zara breaks down what...
-
The Operating Era: Roche’s $1.05B PathAI Deal, AI Governance & OEM Margin Stress
We have officially entered the "Operating Era" of medical imaging AI. The market has shifted from simply proving algorithms work to deciding who controls the workflow and how margins are defended. This week on Marketstrat Pulse Insights, we break down what this means for the future of healthcare...
-
The 2026 AI Playbook: Workflow Control, Aidoc's $150M Raise & GE's Margin Reset
The moat for imaging AI has officially shifted from isolated model performance to capitalized platform scale, workflow ownership, and operating leverage. This week on Marketstrat Pulse Insights for May 1, 2026, we break down what this means for the future of healthcare technology. We explore...
-
Coverage Speed is the New Moat: RAPID, Covera/Medmo & MRI Throughput
The market's center of gravity is moving from basic algorithm adoption to reimbursable, evidence-governed workflow infrastructure. This week on Marketstrat Pulse Insights for April 24, 2026, we break down the new CMS and FDA RAPID pathway, which could radically reduce Medicare coverage timing for...
-
Owned Workflow Gets Paid: Reimbursable AI, Sectra M&A & ARRS Reality Checks
The era of the standalone AI algorithm is giving way to a new commercial reality: owned workflow surfaces are starting to get paid. This week on Marketstrat Pulse Insights for April 17, 2026, we break down how opportunistic AI is finally monetizing, and why platform control is tightening across…
more -
Platform Control, Breast AI Labor Proof & Cyber Reality Checks
Episode Description / Show Notes:The era of standalone medical AI is fading as tech giants move to own the digital infrastructure. This week on Marketstrat Pulse Insights for March 20, 2026, we break down GE HealthCare's $2.3 billion acquisition of Intelerad and what it means for enterprise…
more -
HIMSS26 & The AI Control Surface: Workflow, Helium Risk, and MIS Automation
Episode Description / Show Notes: The era of the standalone AI algorithm is officially over. This week on Marketstrat Pulse Insights for March 13, 2026, we break down the massive shift toward enterprise imaging orchestration dominating the floor at HIMSS26. Hospitals are no longer buying abstract...
-
Medical Imaging AI Grows Up: Consolidation, ECR 2026 & Reimbursement Reality Checks
Episode Summary:The era of the standalone medical AI algorithm is officially over. This week on Marketstrat Pulse Insights, AI host Marcus breaks down the rapid shift toward bundled, heavy-duty AI infrastructure in hospitals. From massive market consolidation to the latest vendor strategies at…
more -
RadNet’s $250M Gleamer Deal, GE’s "Virtual Capacity" & AI as Infrastructure
In this week’s Markintel Pulse (Week of Feb 27, 2026), we explore a massive shift in healthcare technology: AI is officially moving from a "shiny point-solution" to fundamental hospital infrastructure. Key Signals Covered: The Deal of the Year: RadNet acquires French AI firm Gleamer for $250M,...
-
Tariff Reset (15% Cost) & The Robot Fleet War: Medtronic vs. Intuitive vs. J&J
Episode Description:In this week’s Markintel Pulse (Week of Feb 20, 2026), we break down the shift from "Executive Volatility" to "Legislative Uncertainty." Key Signals Covered: The Tariff Reset: Supreme Court strikes down IEEPA, but the new 15% Section 122 surcharge creates a confirmed cost...
-
The Reimbursement Cliff: Imaging AI’s $575 Risk, Median’s Clearance & Tempus Distribution
Episode Description:In this week’s Markintel Pulse (Week of Feb 13, 2026), we analyze the massive financial spread defining Imaging AI economics. Key Signals Covered: The Reimbursement Cliff: CMS keeps AI CT codes in APC 1508 (~$650), but claims data suggests a repricing risk to ~$75. We break…
more -
ROI Telemetry is the New Moat: NGS Non-Coverage, RapidAI & Medtronic
Episode Description:In this week’s Markintel Pulse briefing (Week of Feb 6, 2026), we break down why "Accuracy" is no longer the winning sales pitch for Imaging AI. Key Signals Covered: The Reimbursement Warning: NGS releases a draft LCD proposing non-coverage for brain MRI AI quantification. We...
-
Imaging AI Becomes Infrastructure: The MASAI Outcomes, New CPT Codes & The "Quant" Era
Episode Description:In this week’s Markintel Pulse briefing (Week of Jan 30, 2026), we break down the shift from "AI Pilots" to "Critical Infrastructure." Key Signals Covered: The "Outcomes" Breakthrough: The MASAI trial reports a ~12% reduction in interval cancer rates with AI-supported...
-
Radiology AI: The Shift from Apps to Platforms (Aidoc, BMS + Microsoft, & The New ROI)
In this week’s Markintel Pulse briefing (Week of Jan 23, 2026), we analyze the structural shift in Radiology AI from single-point "apps" to enterprise-grade platforms. Key Signals Covered: The Platform Win: Aidoc secures FDA clearance for its "Comprehensive Abdomen CT Triage," bundling 14…
more -
MRI Automation, The $14.5B Stroke Deal, and Google's Open Models (Jan 16, 2026)
This Week on the Pulse: MRI Automation: Why Vista AI's $29.5M raise signals a shift from "detection" to "capacity." Strategic M&A: Inside Boston Scientific’s $14.5B acquisition of Penumbra. Tech Layer: Google releases MedGemma 1.5—what open models mean for your competitive moat. About This...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
The executive briefing for MedTech leaders. Each week, Marketstrat breaks down the critical signals in Medical Imaging, AI, and Go-to-Market strategy. We cut through the noise to tell you not just what happened, but what it means for your strategy. Hosted by Zara, Marketstrat's AI Analyst. Guest narration by Marcus.
HOSTED BY
Marketstrat
CATEGORIES
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Marketstrat Pulse Insights have?
Marketstrat Pulse Insights currently has 26 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Marketstrat Pulse Insights about?
The executive briefing for MedTech leaders. Each week, Marketstrat breaks down the critical signals in Medical Imaging, AI, and Go-to-Market strategy. We cut through the noise to tell you not just what happened, but what it means for your strategy. Hosted by Zara, Marketstrat's AI Analyst. Guest...
How often does Marketstrat Pulse Insights release new episodes?
Marketstrat Pulse Insights has 26 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to Marketstrat Pulse Insights?
You can listen to Marketstrat Pulse Insights on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts Marketstrat Pulse Insights?
Marketstrat Pulse Insights is created and hosted by Marketstrat.
URL copied to clipboard!